COX-2 inhibitor | Brand | Marketed in | ||
---|---|---|---|---|
UK | USA | Australia | ||
Lumiracoxib (Prexige) is not in the British National Formulary 47th edition3; however it was first marketed in the UK in September 2003. | ||||
Celecoxib | Celebrex | Yes | Yes | Yes |
Etodolac | Lodine SR | Yes | Yes | No |
Rofecoxib | Vioxx | Yes | Yes | Yes |
Parecoxib | Dynastat | Yes | No | Yes |
Etoricoxib | Arcoxia | Yes | No | No |
Valdecoxib | Bextra | Yes | Yes | No |
Meloxicam | Mobic | Yes | Yes | Yes |
Lumiracoxib | Prexige | Yes | No | No |